Chinese weight-correction model for maternal serum markers in Down syndrome prenatal screening

International Journal of Gynecology and Obstetrics

Volumn 97, Issue 1, 2007, Pages 21-25

  Wang, Yuan Yuan ^a,b   Zhang, Li ^d   Peng, Zuo Qi ^a   Cui, Qin Zi ^d   Ma, Xu ^a,b,c  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Shen Yang Maternal and Child Health Hospital   (China)

Author keywords

Down syndrome; Prenatal screening; Regression model; Weight correction model

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; BODY WEIGHT; CHINA; DOWN SYNDROME; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY;

EID: 33847368628     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.11.013     Document Type: Article

References (22)

1. Brock D.J. Maternal serum alpha-fetoprotein as screening test for Down syndrome. Lancet 1 8389 (1984) 1292
2. Wald N.J., Cuckle H., Brock J.H., Peto R., Polani P.E., and Woodford F.P. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spinal bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1 8026 (1977) 1323-1332
3. Palomaki G.E., and Neveux L.M. Using multiples of the median to normalize serum protein measurements. Clin Chem Lab Med 39 (2001) 1137-1145
4. Merkatz I.R., Nitowsky H.M., Macri J.N., and Johnson W.E. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148 7 (1984) 886-894
5. Wolf G.C., Byrn F.W., McConnell T.S., and Khazaeli M.B. Amniotic fluid levels of human chorionic gonadotropin and its alpha and beta subunits in second-trimester chromosomally abnormal pregnancies. Prenat Diagn 12 2 (1992) 93-101
6. Wald N.J., Cuckle H.S., Densem J.W., Nanchahal K., Canick J.A., Haddow J.E., et al. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 95 4 (1988) 334-341
7. Casals E., Fortuny A., Grudzinskas J.G., Suzuki Y., Teisner B., Comas C., et al. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG. Prenat Diagn 16 5 (1996) 405-410
8. Wald N.J., Cuckle H.S., Densem J.W., Nanchahal K., Royston P., Chard T., et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 8; 297 6653 (1988) 883-887
9. Ayme S., Aurran Y., Chabal F., Gombert A., Loundou H., Montfort C., et al. Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study. Contracept Fertil Sex 21 2 (1993) 133-143
10. Thornton J.G., Cartmill R.S., Williams J., Holding S., and Lilford R.J. Clinical experience with the triple test for Down's syndrome screening. J Perinat Med 19 3 (1991) 151-154
11. Wald N.J., Rodeck C., Hackshaw A.K., and Rudnicka A.A. SURUSS in perspective. BJOG 111 6 (2004) 521-531
12. Wald N., Cuckle H., Boreham J., Terzian E., and Redman C. The effect of maternal weight on maternal serum alpha-fetoprotein levels. Br J Obstet Gynaecol 88 11 (1981) 1094-1096
13. Verloes A., Schoos R., Herens C., Vintens A., and Koulischer L. A prenatal trisomy 21 screening program using α-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood. Am J Obstet Gynecol 172 1 Pt 1 (1995) 167-174
14. Law L., Lau T., Fung T., Rogers M.S., and Hjelm M. Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong. Chin Med J 112 8 (1999) 754-757
15. Hsu J.J., Hsieh T.T., Soong Y.K., and Kuo B. The influence of maternal weight correction formulas in Asian Down syndrome screening using alpha-fetoprotein and free beta-human chorionic gonadotropin. J Matern Fetal Investig 8 2 (Jun 1998) 66-70
16. Cuckle H.S., Wald N.J., and Thompson S.G. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94 5 (1987) 387-402
17. Neveux L.M., Palomaki G.E., Larrivee D.A., Knight G.J., and Haddow J.E. Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn 16 (1996) 1115-1119
18. Crossley J.A., Aitken D.A., Waugh S.M., Kelly T., and Connor J.M. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening. Prenat Diagn 22 (2002) 247-255
19. Tsukerman G.L., Gusina N.B., and Cuckle H.S. Maternal serum screening for Down syndrome in the first trimester: experience from Belarus. Prenat Diagn 19 (1999) 499-504
20. Kennedy D.M., Edwards V.M., and Worthington D.J. Evaluation of different weight correction methods for antenatal serum screening using data from two multi-centre programmes. Ann Clin Biochem 36 Pt 3 (May 1999) 359-364
21. Jou H.J., Wu S.C., Lu Y.M., Liao W.C., and Hsieh F.J. Weight-correction formula for maternal serum screening for Down syndrome in Taiwan. J Formos Med Assoc 99 12 (2000) 931-935
22. Wald N., Cuckle H., Boreham J., Terzian E., and Redman C. The effect of maternal weight on maternal serum alpha-fetoprotein levels. Br J Obstet Gynaecol 88 11 (1981) 1094-1096